The data below includes all participants who enrolled in the VISION study and had their identities verified. This information depicted is from the entry visit. The information below is current as of May 2023.

Total Enrollment

This line graph depicts total enrollment since the opening of the study in October 2022. Current enrollment as of May 2023 is 1,239. 1,189 enrolled with a recent infection and 50 participants enrolled as a rebounder.

Enrollment by County

This map of North Carolina counties depicts the number of enrollments across the state by zipcode. The darker blue areas have a higher total number of enrollments than the lighter blue areas. Most enrollments are in the Triangle with about 80 counties having at least one enrollment.

Sex at Birth

This pie chart depicts the percentage of the total number of study participants enrolled who were born female and born male. 71% were born female and 29% were born male. The total number of participants included in this analysis is 1,239.

Gender Identity

This pie chart depicts the percentage of the total number of study participants enrolled and their current gender identity. 70% female; 28% male, 2% Other. The total number of participants included in this analysis is 1,239.
Other includes: non-binary, other sex, prefer not to answer, transgender female and transgender male

Age at Enrollment

This bar chart depicts the number of study participants enrolled and their age ranges. 14% 18-30 years old, 19% 31-40 years old, 21% 41-50 years old, 19% 51-60 years old, 17% 61-70 years old, 10% 71-90 years old

Race

This pie chart depicts the percentage of the total number of study participants enrolled and their race. <1% American Indian or Alaska Native, 3% Asian, 12% Black or African American, 1% Other, <1% Prefer not to answer, 2% Two or more races, 81% White. The total number of participants included in this analysis is 1,239

Ethnicity

This pie chart depicts the percentage of the total number of study participants enrolled and their ethnicity. 4% Hispanic, 96% Not Hispanic, <1% Prefer not to answer. The total number of participants included in this analysis is 1,239.

Number of COVID-19 Vaccines at Entry

This bar chart depicts the number of study participants who endorse receiving between 0-6 vaccines at entry. 7% had no vaccines, 3% 1 vaccine, 17% 2 vaccines, 22% 3 vaccines, 28% 4 vaccines, 23% 5 vaccine, 1% 6 vaccines.

Long COVID at Entry

This pie chart depicts the percentage of the total number of study participants enrolled and if they had Long COVID at entry. Please note that this question was introduced in January 2023 and the percentages shown are for participants who enrolled after this time point. 83% No, 17% Yes. The total number of participants included in this analysis is 187.

COVID-19 Oral Treatment at Entry

This pie chart depicts the percentage of the total number of study participants enrolled and if they endorsed taking Paxlovid, Molnupiravir or No Treatment at entry. No treatment is defined as not taking either Molnupiravir or Paxlovid. 5% Molnupiravir, 39% Paxlovid, 56% No Treatment. The total number of participants included in this analysis is 1,234.